-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Amphastar Pharmaceuticals, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2012 to 2023.
- Amphastar Pharmaceuticals, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $9.01M, a 34.1% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $33.4M, a 38.7% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2023 was $28.9M, a 34% increase from 2022.
- Amphastar Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2022 was $21.5M, a 23.1% increase from 2021.
- Amphastar Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2021 was $17.5M, a 18.3% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)